Literature DB >> 17520204

Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.

Koichi Suda1, Bunsei Nobukawa, Shigetaka Yamasaki, Keiko Abe, Susumu Matsukuma, Fujihiko Suzuki.   

Abstract

BACKGROUND/
PURPOSE: We aimed to elucidate the origin/primary site of invasive ductal adenocarcinoma of the pancreas, based on the distribution of intraductal carcinoma components. These components were identified by a mural elastic fiber cuff.
METHODS: Thirteen specimens from patients with invasive ductal adenocarcinoma (microscopically, less than 2 cm in diameter) of the pancreas were studied histopathologically. Variants of invasive ductal adenocarcinoma and intraductal papillary-mucinous carcinoma were excluded.
RESULTS: Intraductal carcinoma components of invasive ductal adenocarcinoma were found in 12 of the specimens 13 (92%), and were observed within the tumor mass and/or on its boundary, or outside the tumor mass. Intraductal components were characterized by low papillary projections lacking a fibrovascular core, with/without surrounding tubular structures, or by irregular stratification and pleomorphism of the epithelial cells. Invasive components mostly showed a tubular pattern with desmoplasia. The distribution of the intraductal components in the 12 specimens was as follows: in 9 (75%), they were in both the main pancreatic duct and large branch ducts; and in 3, they were in the smaller branch ducts only.
CONCLUSIONS: Invasive ductal adenocarcinomas of the pancreas may originate most frequently from the main pancreatic duct or larger branch ducts, while the smaller ducts are less often the site of cancer origin.

Entities:  

Mesh:

Year:  2007        PMID: 17520204     DOI: 10.1007/s00534-006-1137-x

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  1 in total

1.  Poor prognosis of common-type invasive ductal carcinomas that originate in the branching pancreatic duct.

Authors:  Masataka Ando; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Yuji Nimura; Kenji Yamao; Masato Nagino; Akio Yanagisawa
Journal:  Surg Today       Date:  2014-12-05       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.